Nurix Therapeutics (NRIX) Net Cash Flow Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) Net Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
198.34% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
467.41% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-14,223.53% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
453.08% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Nurix Therapeutics |
1.93 Bn |
1.39 Bn |
- |
-415.73% |
| Date | Value |
|---|
| Feb 28, 2026 |
-415.73% |
| Nov 30, 2025 |
1,438.59% |
| Aug 31, 2025 |
67.57% |
| May 31, 2025 |
-87.54% |
| Feb 28, 2025 |
-607.96% |
| Nov 30, 2024 |
-11.12% |
| Aug 31, 2024 |
-6.56% |
| May 31, 2024 |
163.82% |
| Feb 29, 2024 |
84.42% |
| Nov 30, 2023 |
-27.16% |
| Aug 31, 2023 |
-376.51% |
| May 31, 2023 |
168.16% |
| Feb 28, 2023 |
-2,681.55% |
| Nov 30, 2022 |
125.28% |
| Aug 31, 2022 |
114.82% |
| May 31, 2022 |
-160.24% |
| Feb 28, 2022 |
-115.81% |
| Nov 30, 2021 |
54.21% |
| Aug 31, 2021 |
-138.28% |
| May 31, 2021 |
-39.93% |
